glp 1 drops fda approved Lilly is now pharma's top revenue company. It just got approval for an oral GLP-1, but Wall Street isn't celebrating FDA Says to Drop Suicide

The tumor-specific isoform ct-OATP1B3-V1 enhances chemotherapy sensitivity by localizing to the plasma membrane and importing drugs

Many factors deplete NAD+ levels in the body, including extensive free radical-induced DNA damage, chronic inflammation and immune activation, aging-related increase in consumption, and decrease in synthesis

Innovation Directions Rather than pursuing oral convenience, leading companies focus on injectable innovation: Extended-release formulations reducing injection frequency (monthly, quarterly) Multi-target mechanisms enhancing efficacy beyond single GLP-1 activation Combination therapies addressing multiple obesity pathways simultaneously Improved delivery devices enhancing patient experience with injections Amgens monthly MariTide exemplifies this approach, achieving 20% weight loss with just 12 annual injections versus 52 for weekly alternatives

It is important to talk with your doctor about these risks to keep your safety first